» Articles » PMID: 33741451

Regulation of Nrf2 Signaling Pathway in Heart Failure: Role of Extracellular Vesicles and Non-coding RNAs

Overview
Date 2021 Mar 20
PMID 33741451
Citations 28
Authors
Affiliations
Soon will be listed here.
Abstract

The balance between pro- and antioxidant molecules has been established as an important driving force in the pathogenesis of cardiovascular disease. Chronic heart failure is associated with oxidative stress in the myocardium and globally. Redox balance in the heart and brain is controlled, in part, by antioxidant proteins regulated by the transcription factor Nuclear factor erythroid 2-related factor 2 (Nrf2), which is reduced in the heart failure state. Nrf2 can, in turn, be regulated by a variety of mechanisms including circulating microRNAs (miRNAs) encapsulated in extracellular vesicles (EVs) derived from multiple cell types in the heart. Here, we review the role of the Nrf2 and antioxidant enzyme signaling pathway in mediating redox balance in the myocardium and the brain in the heart failure state. This review focuses on Nrf2 and antioxidant protein regulation in the heart and brain by miRNA-enriched EVs in the setting of heart failure. We discuss EV-mediated intra- and inter-organ communications especially, communication between the heart and brain via an EV pathway that mediates cardiac function and sympatho-excitation in heart failure. Importantly, we speculate how engineered EVs with specific miRNAs or antagomirs may be used in a therapeutic manner in heart failure.

Citing Articles

Hybridisation of in silico and in vitro bioassays for studying the activation of Nrf2 by natural compounds.

Nguyen B, Le N, Nguyen T, Nguyen H, Yen C, Nguyen M Sci Rep. 2024; 14(1):31222.

PMID: 39732775 PMC: 11682235. DOI: 10.1038/s41598-024-82559-5.


LncRNA UCA1 enhances NRF2 expression through the mA pathway to mitigate oxidative stress and ferroptosis in aging cardiomyocytes.

Jiao K, Cheng J, Wang Q, Hao M J Bioenerg Biomembr. 2024; 56(6):607-617.

PMID: 39538055 DOI: 10.1007/s10863-024-10045-8.


Extracellular Vesicle-Derived Non-Coding RNAs: Key Mediators in Remodelling Heart Failure.

Zhao J, Huang H Curr Issues Mol Biol. 2024; 46(9):9430-9448.

PMID: 39329911 PMC: 11430706. DOI: 10.3390/cimb46090559.


Progress and Challenges of Understanding Cardiorenal Syndrome Type 3.

Neres-Santos R, Armentano G, da Silva J, Falconi C, Carneiro-Ramos M Rev Cardiovasc Med. 2024; 24(1):8.

PMID: 39076878 PMC: 11270482. DOI: 10.31083/j.rcm2401008.


Hypoxic extracellular vesicles from hiPSCs protect cardiomyocytes from oxidative damage by transferring antioxidant proteins and enhancing Akt/Erk/NRF2 signaling.

Bobis-Wozowicz S, Paw M, Sarna M, Kedracka-Krok S, Nit K, Blazowska N Cell Commun Signal. 2024; 22(1):356.

PMID: 38982464 PMC: 11232324. DOI: 10.1186/s12964-024-01722-7.


References
1.
Marin-Garcia J, Akhmedov A . Epigenetics of the failing heart. Heart Fail Rev. 2015; 20(4):435-59. DOI: 10.1007/s10741-015-9483-x. View

2.
Xiao J, Gao R, Bei Y, Zhou Q, Zhou Y, Zhang H . Circulating miR-30d Predicts Survival in Patients with Acute Heart Failure. Cell Physiol Biochem. 2017; 41(3):865-874. PMC: 5509048. DOI: 10.1159/000459899. View

3.
Morimoto T, Sunagawa Y, Kawamura T, Takaya T, Wada H, Nagasawa A . The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats. J Clin Invest. 2008; 118(3):868-78. PMC: 2248328. DOI: 10.1172/JCI33160. View

4.
Pan H, Guan D, Liu X, Li J, Wang L, Wu J . SIRT6 safeguards human mesenchymal stem cells from oxidative stress by coactivating NRF2. Cell Res. 2016; 26(2):190-205. PMC: 4746611. DOI: 10.1038/cr.2016.4. View

5.
Chen H, Chang H, Chang J, Tang Y, Cheng Y, Lin L . Enhanced B-Raf-mediated NRF2 gene transcription and HATs-mediated NRF2 protein acetylation contributes to ABCC1-mediated chemoresistance and glutathione-mediated survival in acquired topoisomerase II poison-resistant cancer cells. Free Radic Biol Med. 2017; 113:505-518. DOI: 10.1016/j.freeradbiomed.2017.10.375. View